New study: Technology enables safe fasting on Yom Kippur for type 1 diabetes patients

A new study published in the Journal of Diabetes Science and Technology finds that automated insulin pumps allow most type 1 diabetes patients to fast safely on Yom Kippur. 71.5% of participants completed the fast without major complications, and no cases of severe hypoglycemia or diabetic ketoacidosis were recorded.

A new study published in the Journal of Diabetes Science and Technology finds that automated insulin pump technology allows most type 1 diabetes (juvenile diabetes) patients to fast safely on Yom Kippur. The study, conducted ahead of the fast, found that 71.5% of participants completed the fast without major complications. Dr. Eli Hefetz, father of a child with diabetes, noted that no life-threatening complications, severe hypoglycemia, or diabetic ketoacidosis (DKA) were recorded. During the fast, blood sugar control improved: participants were within the target range 80.7% of the time, compared to 72% in the week before the fast. A key finding: early preparation and medical consultation are essential. Dr. Floris Levy-Khademi explained that 68% of participants adjusted their pump settings in advance, and 84.5% of them completed the fast, compared to only 40% of those who did not adjust. Adjusting the pump increased the chances of success eightfold.